We are live on
!
Find out more
Parnassus Investments Portfolio holdings
AUM
$37.4B
Turnover
15.07%
1-Year Est. Return
35.42%
This Fund
S&P 500
This Quarter
Est. Return
+16.02%
1 Year Est. Return
+35.42%
3 Year Est. Return
+106.24%
5 Year Est. Return
+128.96%
10 Year Est. Return
+492.3%
AUM
$25.4B
AUM Growth
+$2.4B
(+10%)
Cap. Flow
-$918M
Cap. Flow
% of AUM
-3.62%
Top 10 Holdings %
Top 10 Hldgs %
31.21%
Holding
89
New
2
Increased
26
Reduced
36
Closed
2
Avg Time Held
3.4
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$152M |
| 2 |
AbbVie
ABBV
|
+$139M |
| 3 |
Biogen
BIIB
|
+$88.2M |
| 4 |
CERN
Cerner Corp
CERN
|
+$85.3M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$65.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$427M |
| 2 |
Sempra
SRE
|
+$246M |
| 3 |
CELG
Celgene Corp
CELG
|
+$166M |
| 4 |
United Parcel Service
UPS
|
+$159M |
| 5 |
CVS Health
CVS
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 17.11% |
| 3 | Industrials | 15.18% |
| 4 | Financials | 12.92% |
| 5 | Consumer Staples | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Cadence Design Systems
CDNS
$87.9B
| $914M | 3.6% |
14,385,382
-6,746
| -0% | -$357K |
2018 Q2
3 quarters
|
|
2
Linde
LIN
$229B
| $879M | 3.47% |
4,995,873
-33,460
| -0.7% | -$5.56M |
2018 Q4
1 quarter
|
|
|
3
Gilead Sciences
GILD
$194B
| $850M | 3.35% |
13,074,555
+2,288,767
| +21% | +$152M |
2013 Q2
23 quarters
|
|
4
Walt Disney
DIS
$191B
| $789M | 3.11% |
7,109,165
-4,960
| -0.1% | -$554K |
2016 Q2
11 quarters
|
|
5
Synopsys
SNPS
$86.5B
| $774M | 3.05% |
6,723,664
-71,497
| -1% | -$7.09M |
2018 Q2
3 quarters
|
|
6
DELISTED
Hologic
HOLX
| $757M | 2.99% |
15,640,395
+100,833
| +0.6% | +$4.55M |
2017 Q3
6 quarters
|
|
7
Mastercard
MA
$538B
| $750M | 2.96% |
3,185,400
+51,389
| +2% | +$11.1M |
2013 Q2
23 quarters
|
|
8
American Express
AXP
$211B
| $746M | 2.94% |
6,829,551
-471,745
| -6% | -$49.6M |
2015 Q1
16 quarters
|
|
9
3M
MMM
$84.6B
| $732M | 2.89% |
4,212,003
-2,391
| -0.1% | -$403K |
2018 Q2
3 quarters
|
|
10
Clorox
CLX
$10.4B
| $723M | 2.85% |
4,505,204
-28,828
| -0.6% | -$4.47M |
2017 Q1
8 quarters
|
|
11
Charles Schwab
SCHW
$159B
| $668M | 2.63% |
15,616,327
-7,451
| -0% | -$336K |
2013 Q2
23 quarters
|
|
|
CERN
12
DELISTED
Cerner Corp
CERN
| $650M | 2.56% |
11,361,322
+1,531,499
| +16% | +$85.3M |
2018 Q1
4 quarters
|
|
13
Verisk Analytics
VRSK
$24.3B
| $637M | 2.51% |
4,788,587
-2,012
| -0% | -$245K |
2013 Q2
23 quarters
|
|
14
Danaher
DHR
$162B
| $634M | 2.5% |
5,416,539
-45,478
| -0.8% | -$4.66M |
2015 Q2
15 quarters
|
|
15
VF Corp
VFC
$6.64B
| $628M | 2.48% |
7,677,367
-3,910
| -0.1% | -$305K |
2015 Q4
13 quarters
|
|
|
16
CVS Health
CVS
$118B
| $628M | 2.48% |
11,639,429
-2,152,831
| -16% | -$133M |
2013 Q2
23 quarters
|
|
17
Waste Management
WM
$89.7B
| $611M | 2.41% |
5,876,731
-3,236
| -0.1% | -$316K |
2013 Q2
23 quarters
|
|
18
Sysco
SYY
$40.2B
| $584M | 2.3% |
8,752,593
+393,096
| +5% | +$25.6M |
2013 Q2
23 quarters
|
|
19
Alphabet (Google) Class A
GOOGL
$4.17T
| $580M | 2.29% |
9,858,400
-202,660
| -2% | -$11.4M |
2015 Q3
14 quarters
|
|
20
Motorola Solutions
MSI
$77.5B
| $578M | 2.28% |
4,119,782
-145,380
| -3% | -$18.9M |
2013 Q2
23 quarters
|
|
|
FRC
21
DELISTED
First Republic Bank
FRC
| $554M | 2.18% |
5,510,259
-91,675
| -2% | -$9.03M |
2018 Q1
4 quarters
|
|
22
Microsoft
MSFT
$3.9T
| $553M | 2.18% |
4,692,201
-3,206
| -0.1% | -$350K |
2018 Q4
1 quarter
|
|
23
NVIDIA
NVDA
$5.21T
| $553M | 2.18% |
123,250,040
+4,996,880
| +4% | +$19.4M |
2018 Q4
1 quarter
|
|
|
24
United Parcel Service
UPS
$82.5B
| $527M | 2.08% |
4,718,439
-1,503,144
| -24% | -$159M |
2013 Q2
23 quarters
|
|
25
Xylem
XYL
$24.3B
| $496M | 1.96% |
6,274,124
+26,743
| +0.4% | +$1.95M |
2013 Q3
22 quarters
|
|
Similar funds
Parnassus Investments's Q1 2019 Portfolio in Review
As of Q1 2019, Parnassus Investments held 89 positions worth $25.4B, up 10% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Parnassus Investments withdrew a net $918M in Q1 2019, closing 2 positions and reducing 36 holdings. Its most notable exit was Sempra, an estimated $246M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Parnassus Investments opened a new position in AbbVie worth $137M.
- Parnassus Investments's largest Q1 2019 buy was AbbVie: 1,700,000 shares worth $137M.
- Parnassus Investments added most to Gilead Sciences in Q1 2019, an estimated $152M increase.
- Parnassus Investments's biggest Q1 2019 reduction was Starbucks, cutting an estimated $427M.
- Parnassus Investments fully exited Sempra in Q1 2019, selling an estimated $246M.
- Parnassus Investments's ten largest holdings make up 31% of its $25.4B portfolio in Q1 2019.
- Parnassus Investments opened 2 new positions and closed 2 in Q1 2019.
- Parnassus Investments's portfolio value rose 10% quarter-over-quarter to $25.4B.
Based on Parnassus Investments's 13F filing for Q1 2019, filed 1 May 2019.